Collectively, the overexpression of CAT, MGLL (MAGL), MACROH2A2, and CLIP2 (both isoform1 and isoform2) in non-CBF AML were also significantly upregulated in MRD1-positive samples, indicating possible noteworthy prognostic factors and druggable targets that would require further evaluation. The gene discussed is CLIP2; the disease is acute myeloid leukemia.